108 related articles for article (PubMed ID: 2807179)
1. Prognostic implications of cell kinetics, histopathology and pathologic stage in non-Hodgkin's lymphomas.
Silvestrini R; Costa A; Giardini R; Boracchi P; Del Bino G; Marubini E; Rilke F
Hematol Oncol; 1989; 7(6):411-22. PubMed ID: 2807179
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas.
Veneroni S; Costa A; Motta R; Giardini R; Rilke F; Silvestrini R
Hematol Oncol; 1988; 6(1):21-8. PubMed ID: 3343026
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
[TBL] [Abstract][Full Text] [Related]
5. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
Ding SL; Ko WS; Hwang WS
J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
[TBL] [Abstract][Full Text] [Related]
6. Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.
Costa A; Silvestrini R; Giardini R; Messina-Gabrielli G; Boracchi P; Veneroni S
Br J Cancer; 1992 Oct; 66(4):680-4. PubMed ID: 1419606
[TBL] [Abstract][Full Text] [Related]
7. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
[TBL] [Abstract][Full Text] [Related]
9. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry.
Otter R; Gerrits WB; vd Sandt MM; Hermans J; Willemze R
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1203-10. PubMed ID: 2767109
[TBL] [Abstract][Full Text] [Related]
10. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
11. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of different approaches to investigate cell kinetics.
Silvestrini R; Costa A; Veneroni S; Del Bino G; Persici P
Cell Tissue Kinet; 1988 Mar; 21(2):123-31. PubMed ID: 3060260
[TBL] [Abstract][Full Text] [Related]
14. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
Straus DJ; Gaynor JJ; Leiberman PH; Filippa DA; Koziner B; Clarkson BD
Am J Med; 1987 Feb; 82(2):247-56. PubMed ID: 3812517
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
Azab MB; Henry-Amar M; Rougier P; Bognel C; Theodore C; Carde P; Lasser P; Cosset JM; Caillou B; Droz JP
Cancer; 1989 Sep; 64(6):1208-17. PubMed ID: 2670184
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in non-Hodgkin's malignant lymphoma].
Benesová E; Chrz M; Sálková J; Cieslar P; Friedmann B; Spicka I; Konopásek B; Petruzelka L; Bednár B; Jirásek A
Sb Lek; 1991 Oct; 93(9-10):267-75. PubMed ID: 1821459
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: the value of the working formulation and need for chemotherapy.
Shigematsu N; Kondo M; Mikata A
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1111-8. PubMed ID: 3182343
[TBL] [Abstract][Full Text] [Related]
20. The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party.
Leonard RC; Hayward RL; Prescott RJ; Wang JX
Ann Oncol; 1991 Oct; 2(9):655-62. PubMed ID: 1742221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
